GlassScriptPhysician profile
Alicia Philippou
NPI 1285194951
$1,296.06
in general payments reported to CMS, 2019-2025
11 companies · $452 in 2025
The $452 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $73.79 · 2023: $478 · 2024: $293 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,133 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.27 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $308.41 | 2022-2025 | Entyvio |
| Gilead Sciences, INC. | $247.43 | 2023 | Vemlidy |
| Abbvie INC. | $183.58 | 2022-2025 | |
| Janssen Biotech, INC. | $177.96 | 2024-2025 | Stelara, Tremfya, Simponi |
| Mallinckrodt Hospital Products INC. | $125.01 | 2023 | Terlivaz |
| E.R. Squibb & Sons, L.L.C. | $62.50 | 2023 | Zeposia |
| Celltrion USA INC. | $56.34 | 2024-2025 | Vegzelma |
| Regeneron Healthcare Solutions, INC. | $55.23 | 2025 | Dupixent |
| Medtronic, INC. | $35.44 | 2023-2025 | |
| Ardelyx, INC. | $23.30 | 2025 | Ibsrela |
| Novo Nordisk INC | $20.86 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicia Philippou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.